Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Volume

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Sep 26, 2022 3:20pm

77 Views

Post# 34987379

RE:RE:RE:RE:RE:RE:Volume

I'd still drink out-of-date champagne. Send it to me.

Lee430 wrote: Thera, Power of the mighty retail investor, Pleeeze are you paying attention!...I wont breath a sigh of relief until we are holding above $5 again, hopefully soon as I am running low on Tequila and my celebratory Champange is past the expiration date ;->

qwerty22 wrote:
Just eyeballing the chart it looks like the most daily volume YTD.

stephanedodier wrote: I hope it was not just a pump and dump ....